Lv1
18 积分 2024-07-26 加入
Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid Eye Disease
3个月前
已完结
Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management
6个月前
已完结
IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients: The RESTORE-1 Randomized Clinical Trial
6个月前
已完结
Controversies Surrounding IGF-I Receptor Involvement in Thyroid-Associated Ophthalmopathy
6个月前
已完结
Cre-loxP System-Based Mouse Model for Investigating Graves' Disease and Associated Orbitopathy
6个月前
已完结
FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC
8个月前
已完结
Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid Eye Disease
8个月前
已完结
CAR Macrophages Engineered In Vivo for Attenuating Myocardial Ischemia-Reperfusion Injury
8个月前
已完结
CAR Macrophages Engineered In Vivo for Attenuating Myocardial Ischemia-Reperfusion Injury
8个月前
已完结
皖公网安备34019202002308
